Dian Diagnostics Group Co Ltd (300244):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Dian Diagnostics Group Co Ltd (300244) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8284
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Dian Diagnostics Group Co Ltd (Dian Diagnostics) is a medical diagnostic service provider. The company provides forensic authentication services, commercialization of diagnostic products, research and development in medical diagnostics and contract research services. It offers solutions in service marketing, forensic identification, health inspection, cold chain logistics, diagnostic technology research and development production, CRO, biological sample library and other field. Dian Diagnostics promotes the development of multi-service areas of third-party independent medical diagnostic platforms and integrated development strategies for upstream and downstream industry chains. It provides services to medical institutions across China. The company operates through its research and development center in Zhejiang. Dian Diagnostics is headquartered in Hangzhou, China.

Dian Diagnostics Group Co Ltd (300244) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Dian Diagnostics Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Dian Diagnostics Group Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Dian Diagnostics Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Dian Diagnostics Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Dian Diagnostics Group Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Dian Diagnostics Group Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Dian Diagnostics Group Co Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Hangzhou Tigermed and Dian Diagnostics Form Joint Venture 11
Zhejiang Dian Diagnostics To Form Joint Venture In China 12
Equity Offering 13
Dian Diagnostics to Raise USD170.6 Million in Private Placement of Shares 13
Zhejiang Dian Diagnostics Raises USD157 Million in Private Placement of Shares 14
Dian Diagnostics Group Co Ltd – Key Competitors 15
Dian Diagnostics Group Co Ltd – Key Employees 16
Dian Diagnostics Group Co Ltd – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Strategy And Business Planning 18
Mar 27, 2018: Metabolon and DIAN Open New Metabolomics Laboratory in China 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Dian Diagnostics Group Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Dian Diagnostics Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Dian Diagnostics Group Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Dian Diagnostics Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Dian Diagnostics Group Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Dian Diagnostics Group Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Dian Diagnostics Group Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Hangzhou Tigermed and Dian Diagnostics Form Joint Venture 11
Zhejiang Dian Diagnostics To Form Joint Venture In China 12
Dian Diagnostics to Raise USD170.6 Million in Private Placement of Shares 13
Zhejiang Dian Diagnostics Raises USD157 Million in Private Placement of Shares 14
Dian Diagnostics Group Co Ltd, Key Competitors 15
Dian Diagnostics Group Co Ltd, Key Employees 16
Dian Diagnostics Group Co Ltd, Subsidiaries 17

List of Figures
Dian Diagnostics Group Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Dian Diagnostics Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Dian Diagnostics Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Dian Diagnostics Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Dian Diagnostics Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Dian Diagnostics Group Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Dian Diagnostics Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Dian Diagnostics Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Dian Diagnostics Group Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Dian Diagnostics Group Co Ltd (300244):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Ak Bars Bank:企業の戦略・SWOT・財務分析
    Ak Bars Bank - Strategy, SWOT and Corporate Finance Report Summary Ak Bars Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Ghella SpA:企業の戦略・SWOT・財務情報
    Ghella SpA - Strategy, SWOT and Corporate Finance Report Summary Ghella SpA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • BIM Birlesik Magazalar A.S.:戦略・SWOT・企業財務分析
    BIM Birlesik Magazalar A.S. - Strategy, SWOT and Corporate Finance Report Summary BIM Birlesik Magazalar A.S. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • EWE AG:電力:M&Aディール及び事業提携情報
    Summary EWE AG (EWE) operates in energy, telecommunication and information technology businesses. The company is involved in generation and transmission of energy, gas storage and waste water treatment. EWE plans, builds and operates renewable power generation plants globally. The company operates c …
  • Knoll, Inc.:戦略・SWOT・企業財務分析
    Knoll, Inc. - Strategy, SWOT and Corporate Finance Report Summary Knoll, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Kaman Aerospace Group, Inc.:企業の戦略・SWOT・財務情報
    Kaman Aerospace Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Kaman Aerospace Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • New Zealand Pharmaceuticals Ltd:企業の戦略的SWOT分析
    New Zealand Pharmaceuticals Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Salem Media Group, Inc. (SALM):企業の財務・戦略的SWOT分析
    Salem Media Group, Inc. (SALM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • MSD Pharmaceuticals Pvt Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary MSD Pharmaceuticals Pvt Ltd (MSD India), a subsidiary of Merck & Co Inc, is a healthcare products provider that offers prescription medicines, vaccines, biologic therapies, and animal health products. The company offers pipeline products such as medicines, tablets, capsules, solutions, and p …
  • Neuland Laboratories Ltd (NEULANDLAB):製薬・医療:M&Aディール及び事業提携情報
    Summary Neuland Laboratories Ltd (Neuland Lab), a subsidiary of Neuland Health Sciences Pvt Ltd is an API manufacturing service provider that manufactures active pharmaceutical ingredients, advanced intermediates; and offers chemistry related services. The company provides APIs in various therapeuti …
  • Mondelez International Inc (MDLZ):企業の財務・戦略的SWOT分析
    Mondelez International Inc (MDLZ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Align Technology Inc (ALGN):医療機器:M&Aディール及び事業提携情報
    Summary Align Technology Inc (Align) is a medical device company that designs, manufactures and commercializes comprehensive digital treatment solutions including clear aligners and intraoral scanners and services. The company offers virtually invisible aligners for straightening teeth, providing ad …
  • Cyclenium Pharma Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Cyclenium Pharma Inc (Cyclenium Pharma) is a pharmaceutical research and development company that offers small molecule therapeutics agent producer for drug discovery. The company employs its proprietary customized macrocycles for recognition of topologies technology for discovering and deve …
  • Factor Therapeutics Ltd (FTT)-医療機器分野:企業M&A・提携分析
    Summary Factor Therapeutics Ltd (FTL), formerly Tissue Therapies Ltd is a developer of wound care therapeutics. The company develops treatments for acute and chronic wound healing applications such as chronic skin ulcers and burns. Its lead therapeutic candidate, VF-001 is a targeted growth factor w …
  • Central Japan Railway Company:企業の戦略・SWOT・財務情報
    Central Japan Railway Company - Strategy, SWOT and Corporate Finance Report Summary Central Japan Railway Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Corline Biomedical AB (CLBIO):製薬・医療:M&Aディール及び事業提携情報
    Summary Corline Biomedical AB (Corline Biomedical), formerly Corline Systems AB is a manufacturer of heparin based solutions. The company offers heparin based solutions to improve kidney transplantation, and applications in the field of regenerative medicine. Its regentrative medicines include cytop …
  • Golden Queen Mining Co. Ltd.:企業の戦略・SWOT・財務情報
    Golden Queen Mining Co. Ltd. - Strategy, SWOT and Corporate Finance Report Summary Golden Queen Mining Co. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Hugo Boss AG (BOSS):企業の財務・戦略的SWOT分析
    Hugo Boss AG (BOSS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Soitec SA (SOI):企業の財務・戦略的SWOT分析
    Soitec SA (SOI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Bank of Cyprus Public Company Ltd:企業の戦略・SWOT・財務情報
    Bank of Cyprus Public Company Ltd - Strategy, SWOT and Corporate Finance Report Summary Bank of Cyprus Public Company Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆